Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion type Assertion NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_head.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_provenance.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion evidence source_evidence_literature NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_provenance.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion SIO_000772 14715418 NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_provenance.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion wasDerivedFrom befree-20150227 NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_provenance.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion wasGeneratedBy ECO_0000203 NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_provenance.